help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on March 4, 2008
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-2441
A more recent version of this article appeared on May 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
93/5/1854    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Sijens, P. E.
Right arrow Articles by Lunsing, R. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sijens, P. E.
Right arrow Articles by Lunsing, R. J.
Related Collections
Right arrow Neuroendocrinology and Pituitary
Right arrow Thyroid

Submitted on November 2, 2007
Accepted on February 20, 2008

1H Magnetic Resonance Spectroscopy in Monocarboxalate Transporter 8 Gene Deficiency

Paul E. Sijens*, Lars A. Rödiger, Linda C. Meiners, and Roelineke J. Lunsing

Departments of Radiology (P.E.S., L.A.R., L.C.M.), and Pediatric Neurology (R.J.L), University Medical Center Groningen and University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands

* To whom correspondence should be addressed. E-mail: p.e.sijens{at}rad.umcg.nl.

Context: In monocarboxylate transporter 8 (MCT8) gene deficiency, a syndrome combining thyroid and neurological abnormalities, the central nervous system has not yet been characterized by magnetic resonance spectroscopy (MR spectroscopy).

Objective:We studied whether the degree of dysmyelinization in MCT8 gene deficiency according to MRI, is coupled with abnormalities in brain metabolism.

Design: MRI and MR spectroscopy of the brain were performed twice in two MCT 8 gene deficiency patients, for the first time at age 8–10 months and for the second time at age 17–28 months. The results were compared with those obtained in controls of similar age.

Results: Compared with controls, young children with MCT8 show choline and myo-inositol level increases and N-acetyl aspartate decreases in supraventricular gray and white matter, phenomena associated with the degree of dysmyelinization according to MRI.

Conclusion: MCT8 gene deficiency results in deviant myelinization and general atrophy, which is substantiated by the MR spectroscopy findings of increased choline and myo-insitol levels and decreased N-acetyl aspartate. The observations suggest that different mutations in the MCT8 gene lead to differences in the severity of the clinical spectrum, dysmyelinization and MR spectroscopy detectable changes in brain metabolism.


Key words: Monocarboxylate transporter 8 (MCT8) deficiency • brain metabolism • magnetic resonance spectroscopy







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society